Provided by Tiger Trade Technology Pte. Ltd.

PTC Therapeutics

71.06
+1.241.78%
Post-market: 70.50-0.5623-0.79%16:12 EDT
Volume:897.68K
Turnover:63.18M
Market Cap:5.93B
PE:-116.49
High:71.45
Open:69.67
Low:68.02
Close:69.82
52wk High:90.87
52wk Low:48.28
Shares:83.46M
Float Shares:77.19M
Volume Ratio:0.95
T/O Rate:1.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6100
EPS(LYR):7.78
ROE:-7740.12%
ROA:2.46%
PB:-35.86
PE(LYR):9.13

Loading ...

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 18

BUZZ-PTC Therapeutics dips after convertible bond refinancing

Reuters
·
Jun 16

PTC Therapeutics Prices New 0% Convertible Senior Notes

TIPRANKS
·
Jun 16

BRIEF-PTC Therapeutics Prices $500 Million 0% Convertible Senior Notes Due 2031

Reuters
·
Jun 16

PTC Therapeutics Announces Pricing of Convertible Notes Offering to Refinance 2026 Convertible Notes

THOMSON REUTERS
·
Jun 16

BUZZ-U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex

Reuters
·
Jun 16

PTC Therapeutics Plans $500 Million Convertible Notes Offering to Refinance 2026 Notes

MT Newswires Live
·
Jun 15

BUZZ-PTC Therapeutics falls after $500 mln convertible announced

Reuters
·
Jun 15

PTC Therapeutics plans USD 500 million convertible senior notes offering due 2031

Reuters
·
Jun 15

PTC Therapeutics - to Offer $500 Mln Convertible Senior Notes Due 2031

THOMSON REUTERS
·
Jun 15

PTC Therapeutics - Expects to Repurchase About $50 Mln of Common Stock

THOMSON REUTERS
·
Jun 15

PTC Therapeutics Chief Business Officer Eric Pauwels disposes of common shares worth $1,596,525

Reuters
·
Jun 13

PTC Therapeutics Director Resigns, Moves to Advisory Role

TIPRANKS
·
Jun 10

PTC Therapeutics director Alethia Young resigns from board

Reuters
·
Jun 10

PTC Therapeutics Shares Rise After Upgrade From Citigroup

MT Newswires Live
·
Jun 10

PTC Therapeutics Coverage Assumed by Citigroup at Buy vs Previous Rating of Neutral

Dow Jones
·
Jun 09

Citigroup Upgrades PTC Therapeutics to Buy From Hold, Raise Price Target to $108 From $76

MT Newswires Live
·
Jun 09

PTC Therapeutics Inc : Citigroup Assumes Coverage With Buy VS Neutral Rating; Price Target $108 VS $75

THOMSON REUTERS
·
Jun 09

PTC Therapeutics assumed with Buy from Neutral at Citi

TIPRANKS
·
Jun 09

A Look At PTC Therapeutics (PTCT) Valuation As Models Flag A Potential Discount

Simply Wall St.
·
Jun 06